MTHRF(MTHRF)
MTHRF
No analyst ratings available
No analyst price targets available for MTHRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $393.61B | $431.11B | $472.72B | $519.02B | $593.46B |
| Low | $382.75B | $414.51B | $456.98B | $501.74B | $573.70B |
| High | $411.50B | $460.13B | $499.60B | $548.53B | $627.21B |
| EBITDA Avg | $128.41B | $140.64B | $154.22B | $169.32B | $193.61B |
| Low | $124.86B | $135.23B | $149.08B | $163.68B | $187.16B |
| High | $134.24B | $150.11B | $162.99B | $178.95B | $204.62B |
| EBIT Avg | $117.18B | $128.34B | $140.73B | $154.51B | $176.67B |
| Low | $113.94B | $123.40B | $136.04B | $149.37B | $170.79B |
| High | $122.50B | $136.98B | $148.73B | $163.30B | $186.72B |
| Net Income Avg | $55.41B | $62.31B | $69.63B | $80.63B | $98.03B |
| Low | $53.02B | $59.61B | $66.62B | $77.14B | $93.79B |
| High | $59.51B | $66.91B | $74.78B | $86.59B | $105.28B |
| EPS Avg | $81.83 | $92.00 | $102.83 | $119.06 | $144.76 |
| Low | $78.29 | $88.02 | $98.37 | $113.91 | $138.50 |
| High | $87.88 | $98.81 | $110.43 | $127.86 | $155.46 |
| Analysts (Rev / EPS) | 13 / 1 | 13 / 1 | 9 / 1 | 12 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $93.30B | $103.13B | $99.06B |
| Low | $92.33B | $102.05B | $98.03B |
| High | $94.70B | $104.68B | $100.55B |
| EBITDA Avg | $30.44B | $33.64B | $32.32B |
| Low | $30.12B | $33.29B | $31.98B |
| High | $30.89B | $34.15B | $32.80B |
| EBIT Avg | $27.77B | $30.70B | $29.49B |
| Low | $27.49B | $30.38B | $29.18B |
| High | $28.19B | $31.16B | $29.93B |
| Net Income Avg | $11.50B | $16.22B | $13.21B |
| Low | $11.34B | $16.00B | $13.03B |
| High | $11.72B | $16.54B | $13.47B |
| EPS Avg | $17.15 | $24.20 | $19.71 |
| Low | $16.92 | $23.87 | $19.44 |
| High | $17.48 | $24.67 | $20.09 |
| Analysts (Rev / EPS) | 6 / 1 | 5 / 1 | 3 / 1 |